Company intelligence / Profile preview

MAP Medical Technologies

Tikkakoski, Central FI, Finlandcuriumfinland.fi ↗

Ownership: Private
Employees: ~50
Development stage: Commercial

Overview

MAP Medical Technologies is a leading Nordic manufacturer and distributor of radiopharmaceuticals for PET and SPECT imaging. The company operates GMP-certified facilities in Finland and supplies diagnostic agents across the Nordics and Baltics. It was acquired by Curium in 2019 to expand access to innovative nuclear medicine solutions. Products are used routinely in clinical practice for diagnostic imaging of various serious diseases.

Therapeutic areas: OncologyCardiovascularNeurologyOther
Modalities: RadiopharmaceuticalSmall molecule
Industry: Medical Imaging

Partnerships

Distribution partnership with parent company’s global networkSupplies both own products and distributes broader portfolio from Curium.

Beyond the preview

Go deeper on MAP Medical Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MAP Medical Technologies.

Explore the full profile